Skip to main content

Animations

MJFF Publications

1971 - 1980 of 6420 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2024
  • 2025
  • 2023
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Adeno-associated viral vectors for modeling Parkinson’s disease in non-human primates
    Journal Name: Neural Regeneration Research
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.4103/nrr.nrr-d-24-00896
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29685
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Transcriptomics profiling of Parkinson’s disease progression subtypes reveals distinctive patterns of gene expression
    Journal Name: Journal of Central Nervous System Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/11795735241286821
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Genetics of Parkinson's disease heterogeneity: A genome-wide association study of clinical subtypes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105935
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-56293-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Alpha synuclein overexpression can drive microbiome dysbiosis in mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-82139-7
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Differential Impact of Risk Factors for Cognitive Decline in Heterosexual and Sexual Minority Older Adults in England
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci15010090
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Global cellular proteo-lipidomic profiling of diverse lysosomal storage disease mutants using nMOST
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adu5787
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1
    Journal Name: Chemical Science
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d4sc07532c
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.